started · updated
Aiom calls for increased funding for independent cancer research
During the XXVIII national congress of the Italian Association of Medical Oncology (Aiom) in Rome, leaders expressed urgent concerns regarding the crisis facing independent clinical research in Italy. Massimo Di Maio, president of Aiom, emphasized that while industry-sponsored trials are vital for bringing innovative drugs to market, independent academic research is essential for optimizing therapy use and comparing different treatments.
Data presented at the congress reveals that non-profit clinical studies in Italy account for only 6.4% of the total authorized by the Italian Medicines Agency (Aifa) in 2024. Experts cited several obstacles, including increased procedural complexity due to European regulations, rising costs, and a shortage of dedicated personnel. Furthermore, regulatory hurdles prevent researchers from using drugs already reimbursed by the National Health Service (SSN) to study alternative dosages or schedules, which could potentially lead to significant cost savings for the state.
Francesco Perrone, president of the Aiom Foundation, also highlighted a critical gap in patient awareness. A survey indicated that many breast cancer patients and caregivers are unfamiliar with precision oncology, noting that only 32% are aware of liquid biopsies and only 24% understand the role of Molecular Tumor Boards. The association is calling for institutional support to simplify bureaucracy and increase public funding to ensure the sustainability and competitiveness of Italian medical research.
Entities
AIFA · Aiom · Associazione italiana oncologia medica · Ficog · Fondazione Aiom · Francesco Perrone · Massimo Di Maio · Pope Leo XIV · Rome
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] Non-profit clinical studies account for 6.4% of the total authorized by Aifa in 2024. www.periodicodaily.com
- [○ 1 SOURCE] Pope Leo XIV sent a message of support to the Aiom national congress.
- [● 2 SOURCES] Including international independent trials, non-profit studies represent 14.9% of the total. www.periodicodaily.com
- [● 2 SOURCES] There were 43 non-profit studies authorized by Aifa in 2024 out of 669 total. www.periodicodaily.com
- [● 2 SOURCES] The percentage of independent studies is at its lowest level since 2021. www.periodicodaily.com
- [● 2 SOURCES] The Fata study compared three drugs to find the most effective endocrine therapy for post-menopausal women with breast cancer. www.periodicodaily.com